淚道裝置市場規模、佔有率及成長分析（按產品、應用、最終用途及地區分類）－2026-2033年產業預測

預計到 2024 年，淚道裝置市場規模將達到 1.7147 億美元，到 2025 年將達到 1.7798 億美元，到 2033 年將達到 2.3986 億美元，預測期（2026-2033 年）的複合年成長率為 3.8%。

淚道器材市場正經歷強勁成長，這主要得益於各年齡層對眼部疾病的認知和診斷水準的提高。眼科疾病發病率的上升推動了對淚小管栓塞、淚道支架和沖洗系統等先進解決方案的需求。技術進步和精細的手術技巧也在改善患者的治療效果，進一步促進了市場擴張。人口老化和老齡化相關眼科疾病率的上升是推動該領域持續成長的主要因素。製造商和醫療服務提供者致力於創新研發，以滿足淚道疾病患者不斷變化的需求，同時專注於提升醫療品質和舒適度。監管政策和報銷政策正在顯著影響市場動態，為眼科器械行業的企業提供了廣泛的發展機會。

淚道裝置市場促進因素

淚道系統設備市場的主要驅動力是全球眼科疾病率的上升。人口老化、生活方式的改變以及螢幕使用時間的增加是造成這一現象的原因，這些因素都會導致乾眼症和各種淚道系統疾病等問題。隨著人們對這些問題的認知不斷提高，對用於輔助診斷和治療這些疾病的淚道系統設備的需求也隨之成長。這種日益成長的需求不僅促使人們更加關注創新解決方案，也顯著推動了整個淚道系統設備市場的擴張。

淚道醫療設備市場的限制

淚道器材市場面臨的主要挑戰之一是嚴格的法規環境，這往往導致新產品和改良產品核准流程的延誤。監管機構，尤其是在北美和歐洲，對醫療設備製定了嚴格的標準，從而延長了創新產品的上市時間。這種複雜的法規結構會阻礙創新步伐和整體市場成長，對現有企業和新參與企業都產生影響。這些限制會制約企業的發展機遇，並限制其快速回應不斷變化的患者需求和技術進步的能力。

淚道裝置市場趨勢

淚道器材市場正經歷著向微創手術的顯著轉變，這反映出患者和醫療服務提供者越來越傾向於選擇能夠確保更短恢復時間和更高舒適度的治療方案。這一趨勢正在推動創新，並促使先進的微創淚道器材（包括微型內視鏡和專用導管）的研發，以有效治療淚道系統疾病。隨著對最大限度減少術後併發症的手術方案的需求不斷成長，製造商正在加強研發投入，以調整產品線，滿足不斷變化的患者照護需求。這正在塑造淚道器材市場的未來。

目錄

介紹

• 調查目標
• 調查範圍
• 定義

調查方法

• 資訊收集
• 二手資料和一手資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分市場機會分析

市場動態與展望

• 市場規模
• 市場動態
  • 促進因素和機遇
  • 限制與挑戰
• 波特分析

關鍵市場考察

• 關鍵成功因素
• 競爭程度
• 關鍵投資機會
• 市場生態系統
• 市場吸引力指數（2025）
• PESTEL 分析
• 總體經濟指標
• 價值鏈分析
• 定價分析
• 案例研究
• 監管環境
• 專利分析

全球淚道設備市場規模（按產品和複合年成長率分類）（2026-2033 年）

• 插管套裝
• 支架和導管
• 套管和刮刀
• 擴充器

全球淚道裝置市場規模（按應用及複合年成長率分類）（2026-2033 年）

• 青光眼
• 乾眼症
• 淚腺炎症
• 溢淚
• 其他

全球淚道設備市場規模（按最終用途和複合年成長率分類）（2026-2033 年）

• 醫院
• 診斷中心
• 門診護理中心 (ACC)

全球淚道裝置市場規模及複合年成長率（2026-2033）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 亞太其他地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地區
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前五大公司對比
• 主要企業的市場定位（2025 年）
• 主要市場參與者所採取的策略
• 近期市場趨勢
• 公司市佔率分析（2025 年）
• 主要企業公司簡介
  • 公司詳情
  • 產品系列分析
  • 依業務板塊進行公司股票分析
  • 2023-2025年營收年比比較

主要企業簡介

• FCI Ophthalmics（France）
• Kaneka Corporation（Japan）
• Cook Group（USA）
• BVI（UK）
• Rumex International（USA）
• Bess Medical Technology GmbH（Germany）
• Bausch and Lomb Incorporated（USA）
• Braun Melsungen AG（Germany）
• OASIS Medical, Inc.（USA）
• Beaver-Visitec International（USA）
• FC Optics Ltd.（Israel）
• OptiMedica Corporation（USA）
• Diamatrix Ltd.（UK）
• FCI SAS（France）
• Novartis AG（Switzerland）
• Eye Kon Medical, Inc.（USA）

結論與建議

Lacrimal Devices Market size was valued at USD 171.47 Million in 2024 and is poised to grow from USD 177.98 Million in 2025 to USD 239.86 Million by 2033, growing at a CAGR of 3.8% during the forecast period (2026-2033).

The lacrimal devices market is experiencing robust growth driven by heightened awareness and diagnosis of ophthalmic conditions across demographics. The rising incidence of eye disorders has spurred increased demand for advanced solutions, including punctal plugs, lacrimal stents, and irrigation systems. Technological advancements and refined surgical techniques have also enhanced patient outcomes, further fueling market expansion. The aging population, coupled with a rise in age-related eye conditions, ensures sustained growth in this sector. Manufacturers and healthcare providers are dedicated to innovative developments that cater to the evolving needs of patients suffering from lacrimal disorders, focusing on enhancing care quality and comfort. Regulatory influences and reimbursement policies significantly shape market dynamics, presenting promising opportunities for companies in the ophthalmic devices landscape.

Top-down and bottom-up approaches were used to estimate and validate the size of the Lacrimal Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Lacrimal Devices Market Segments Analysis

Global Lacrimal Devices Market is segmented by Product, Application, End-use and region. Based on Product, the market is segmented into Intubation Sets, Stents and Tubes, Cannula and Spatula and Dilators. Based on Application, the market is segmented into Glaucoma, Dry Eye, Lacrimal Gland Inflammation, Epiphora and Others. Based on End-use, the market is segmented into Hospitals, Diagnostic Centers and Ambulatory Care Centers (ACC). Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Lacrimal Devices Market

The lacrimal devices market is primarily propelled by the rising prevalence of eye disorders on a global scale. Contributing factors include an aging population, lifestyle changes, and the surge in screen time, all of which lead to conditions such as dry eye syndrome and various lacrimal system disorders. As awareness of these issues grows, so does the demand for lacrimal devices designed to assist in the diagnosis and treatment of these conditions. This heightened need not only enhances the focus on innovative solutions but also significantly fuels the overall expansion of the lacrimal devices market.

Restraints in the Lacrimal Devices Market

A significant challenge facing the lacrimal devices market is the rigorous regulatory environment, which often results in delays when seeking approvals for new products or modifications. Regulatory bodies, especially in North America and Europe, impose strict standards for medical devices, leading to prolonged timelines for bringing innovations to market. This complex regulatory framework can hinder both the pace of innovation and the overall growth of the market, affecting established companies as well as new market entrants. Such constraints can restrict opportunities for advancement and limit the ability to respond swiftly to evolving patient needs and technological advancements.

Market Trends of the Lacrimal Devices Market

The lacrimal devices market is experiencing a pronounced shift towards minimally invasive procedures, reflecting a growing preference among patients and healthcare providers for options that ensure quicker recovery times and enhanced comfort. This trend is catalyzing innovation, leading to the development of advanced minimally invasive lacrimal devices, including microendoscopes and specialized catheters designed to effectively treat lacrimal system disorders. As the demand for procedures that minimize postoperative complications continues to rise, manufacturers are increasingly investing in research and development to align product offerings with these evolving patient care preferences, thereby shaping the future landscape of the lacrimal devices market.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Case Studies
• Regulatory Landscape
• Patent Analysis

Global Lacrimal Devices Market Size by Product & CAGR (2026-2033)

• Market Overview
• Intubation Sets
• Stents and Tubes
• Cannula and Spatula
• Dilators

Global Lacrimal Devices Market Size by Application & CAGR (2026-2033)

• Market Overview
• Glaucoma
• Dry Eye
• Lacrimal Gland Inflammation
• Epiphora
• Others

Global Lacrimal Devices Market Size by End-use & CAGR (2026-2033)

• Market Overview
• Hospitals
• Diagnostic Centers
• Ambulatory Care Centers (ACC)

Global Lacrimal Devices Market Size & CAGR (2026-2033)

• North America (Product, Application, End-use)
  • US
  • Canada
• Europe (Product, Application, End-use)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Application, End-use)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Application, End-use)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Application, End-use)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• FCI Ophthalmics (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Kaneka Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cook Group (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BVI (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Rumex International (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bess Medical Technology GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bausch and Lomb Incorporated (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Braun Melsungen AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• OASIS Medical, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Beaver-Visitec International (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• FC Optics Ltd. (Israel)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• OptiMedica Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Diamatrix Ltd. (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• FCI S.A.S. (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novartis AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eye Kon Medical, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations